AEONAEON Biopharma, Inc.
Earnings
When AEON Biopharma, Inc. reports, what it reported each quarter, and how the stock took the results.
21 quarters. Mar 31, 2021 to Jun 30, 2026. mixed units.
Next results · Q3 2026Report filed
10-Q filed Nov 16, 2026
The 10-Q was filed Nov 16, 2026. Its figures are not on the desk yet.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
Latest results
- Revenue
- —
- —
- Net income
- -$1.16M
- N/M
- EPS
- -$0.02
- N/M
- Revenue
- —
- —
- Net income
- -$11.79M
- N/M
- EPS
- -$0.29
- N/M
- Revenue
- —
- —
- Net income
- -$37.14M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$4.54M
- N/M
- EPS
- -$0.39
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · after-hours | Aug 12, 2026 | 43 d | 10-Q | — | — | -$0.02 | 0.3% | |
| Q1 2026 | Mar 31, 2026 | May 14, 2026 · after-hours | May 14, 2026 | 44 d | 10-Q | — | — | -$0.29 | 4.9% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 30, 2026 · after-hours | Mar 30, 2026 | 89 d | 10-K | — | — | — | 0.0% | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · after-hours | Nov 14, 2025 | 45 d | 10-Q | — | — | -$0.39 | 7.4% | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | — | — | -$0.60 | +15.9% | |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 · after-hours | May 14, 2025 | 44 d | 10-Q | — | — | $2.28 | 2.0% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 24, 2025 · after-hours | Mar 24, 2025 | 83 d | 10-K | — | — | — | 6.9% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | — | — | -$11.24 | 12.8% | |
| Q2 2024 | Jun 30, 2024 | Aug 12, 2024 · after-hours | Aug 12, 2024 | 43 d | 10-Q | — | — | $304.00 | 2.9% | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · after-hours | May 14, 2024 | 44 d | 10-Q | — | — | -$227.87 | 7.8% | |
| FY 2023 | ||||||||||
| Q3 2023 | Sep 30, 2023 | Nov 10, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | — | — | $1.35 | +12.2% | |
| Q2 2023 | Jun 30, 2023 | — | Jul 21, 2023 | 21 d | 10-Q | — | — | -$0.11 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 17, 2023 | 47 d | 10-Q | — | — | -$0.13 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Feb 22, 2023 | 53 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | — | — | -$0.08 | — | |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | — | — | — | — | |
| Q1 2022 | Mar 31, 2022 | — | May 12, 2022 | 42 d | 10-Q | — | — | — | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 28, 2022 | 87 d | 10-K | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | — | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | — | — | — | — | |
| Q1 2021 | Mar 31, 2021 | — | Jun 15, 2021 | 76 d | 10-Q | — | — | — | — | |
Earlier years, FY 2021 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
AEON Biopharma, Inc. · CIK 1837607 · Engraved from SEC EDGAR